Gain Therapeutics, Inc. - GANX

SEC FilingsOur GANX Tweets

About Gravity Analytica

Recent News

  • 05.27.2025 - What Trial Enrollment Looks Like: From Preclinical Screenings to Participation
  • 05.16.2025 - What Is Mitochondrial Complex I and Its Role in Health?
  • 05.08.2025 - Walking Together for a Cure: The 2025 Parkinson’s Unity Walk
  • 04.21.2025 - 12 Self-Care Tips for Parkinson’s Disease
  • 04.21.2025 - Gain Therapeutics Shares New Preclinical Data and Updates on Phase 1b Clinical Study of GT-02287 at AD/PD 2025
  • 04.10.2025 - Supporting Parkinson’s Awareness During April: How You Can Make a Difference
  • 04.05.2025 - The AD/PD Conference: A Global Hub for Advancing Alzheimer’s and Parkinson’s Disease Research

Recent Filings

  • 05.14.2025 - EX-99.1 EX-99.1
  • 05.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 05.14.2025 - 8-K Current report
  • 04.29.2025 - DEF 14A Other definitive proxy statements
  • 04.29.2025 - ARS Annual Report to Security Holders
  • 04.29.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
  • 04.17.2025 - PRE 14A Other preliminary proxy statements
  • 04.10.2025 - 8-K Current report
  • 04.10.2025 - EX-99.1 EX-99.1
  • 03.27.2025 - 8-K Current report